SYRA — Syra Health Cashflow Statement
0.000.00%
Last trade - 00:00- $0.81m
- -$0.98m
- $7.98m
- 51
- 81
- 10
- 45
Annual cashflow statement for Syra Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.004 | -0.11 | -2.12 | -2.94 | -3.76 |
| Depreciation | |||||
| Non-Cash Items | 0 | 0.027 | 0.623 | 0.154 | 0.221 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.004 | -0.006 | -0.763 | -0.023 | 0.544 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 0 | -0.088 | -2.24 | -2.76 | -2.93 |
| Capital Expenditures | 0 | -0.006 | -0.121 | -0.015 | -0.011 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | 0 | -0.006 | -0.121 | -0.015 | -0.011 |
| Financing Cash Flow Items | 0 | 0 | -0.596 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.003 | 0.192 | 2.27 | 6.05 | 2.06 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.003 | 0.097 | -0.097 | 3.28 | -0.885 |